Clinical Trials Directory

Trials / Completed

CompletedNCT03853525

A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After Laser Hair Removal in the Groin and Intimate Area

Safety and Efficacy Evaluation of the Use of Bepantol® Derma Spray After Laser Depilation in the Inguinal Region in Adult Women - 21 Days Use at Home

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Bayer · Industry
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery after a dermatological procedure for hair removal (laser depilation) in the groin and intimate area in adult women. After the hair removal procedure, participants will return within 3 weeks for 3 visits to the study center to investigate the skin condition such as redness, irritation, softness of skin and possible side effects. Study participants will also be asked about their general acceptance of dexpanthenol dermal spray.

Detailed description

The primary objective is to evaluate the efficacy of the test product to aid skin recovery after lasering depilation in the intima and inguinal region. Secondary objectives comprise clinical efficacy with respect to skin hydration, softness, vitality, appearance etc. and skin recovery, consumer judgement of product performance and acceptability, and safety.

Conditions

Interventions

TypeNameDescription
DRUGBAY207543 (Bepanthol, Bepantol® Derma Spray)Product is applied to one side of the inguinal region.
OTHERSemisolid vaselineProduct is applied to one side of the inguinal region.

Timeline

Start date
2019-02-11
Primary completion
2019-03-11
Completion
2019-03-11
First posted
2019-02-25
Last updated
2020-03-11

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03853525. Inclusion in this directory is not an endorsement.